Racial and ethnic disparities were identified in immunotherapy receipt for Black patients with metastatic triple-negative ...

When added to chemotherapy, researchers found no significant difference in overall or progression-free survival between PD-1 ...

Patient-reported outcomes (PROs) were similar among those treated with tivozanib monotherapy and those given combination ...

Higher calcium intake was associated with reduced colorectal cancer risk across tumor sites and calcium sources, according to ...

Although psoriatic arthritis may be more prevalent in White patients, Rebecca Haberman, MD, of NYU Langone Health, emphasizes that the disease affects those across diverse racial and ethnic ...

Panelists discuss how private label agreements facilitate biosimilar market entry by allowing manufacturers to collaborate on ...

Real-world data confirmed the findings of JAVELIN Renal 101, supporting the combination of avelumab and axitinib in advanced renal cell carcinoma (RCC), said Axel Merseburger, MD, University Hospital ...

Susan Escudier, MD, FACP, explains some of the ways Texas Oncology mitigates financial toxicity and improve clinical trial access for underserved patients.

Carrillo, MD, a postdoctoral fellow at City of Hope Comprehensive Cancer Center, discussed findings that show 76% of renal ...

Abstracts presented at the American Society of Clinical Oncology Genitourinary Cancers Symposium reflect the ongoing ...

In this final interview clip, Michael A. Bernstein, MD, stresses the need for effective communication and proactive screening ...

Aditya Bardia, MD, MPH, FASCO, medical oncologist, UCLA Health, discusses findings from the TROPION-Breast01 study on ...